Pyrrolidine Dithiocarbamate Inhibits Nuclear Factor κB and Toll-Like Receptor 4 Expression in Rats with Acute Necrotizing Pancreatitis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: To investigate the expression of Toll-like receptor 4 (TLR4) in the pancreases of rats with acute necrotizing pancreatitis (ANP) and any changes upon treatment with pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear factor κB (NF-κB), as well as to determine the relationship between TLR4 and NF-κB in ANP pathogenesis. Methods: A total of 72 SD rats were randomly divided into three groups, namely, the control (sham-operation), ANP, and ANP with PDTC pretreatment groups. The PDTC-pretreated group was intraperitoneally injected with PDTC at a dose of 100 mg/kg 1 hour before the induction of ANP. The expressions of TLR4 and NF-κB in pancreatic tissue were evaluated by immunohistochemistry and Western blot analysis. The mRNA levels of cytokines tumor necrosis factor α, interleukin (IL)-1β, and IL-6 were measured by reverse transcription polymerase chain reaction. Results: The expressions of TLR4, NF-κB, and cytokine (NF-κB target) genes in the pancreatic tissue increased more significantly in the ANP groups than in the sham-operation group at 3, 6, and 12 hours. Pretreatment with PDTC alleviated the inflammatory activation in the pancreas with ANP, causing a significant decrease in the expressions of TLR4, NF-κB, and cytokine genes in the pancreatic tissue. Conclusions: The expressions of TLR4 and NF-κB were increased in the pancreases of rats with ANP. PDTC not only inhibits NF-κB but also suppresses the expression of TLR4 and downregulates the expression of the related cytokine genes.
Abstract
Background/Aims: To investigate the expression of Toll-like receptor 4 (TLR4) in the pancreases of rats with acute necrotizing pancreatitis (ANP) and any changes upon treatment with pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear factor κB (NF-κB), as well as to determine the relationship between TLR4 and NF-κB in ANP pathogenesis. Methods: A total of 72 SD rats were randomly divided into three groups, namely, the control (sham-operation), ANP, and ANP with PDTC pretreatment groups. The PDTC-pretreated group was intraperitoneally injected with PDTC at a dose of 100 mg/kg 1 hour before the induction of ANP. The expressions of TLR4 and NF-κB in pancreatic tissue were evaluated by immunohistochemistry and Western blot analysis. The mRNA levels of cytokines tumor necrosis factor α, interleukin (IL)-1β, and IL-6 were measured by reverse transcription polymerase chain reaction. Results: The expressions of TLR4, NF-κB, and cytokine (NF-κB target) genes in the pancreatic tissue increased more significantly in the ANP groups than in the sham-operation group at 3, 6, and 12 hours. Pretreatment with PDTC alleviated the inflammatory activation in the pancreas with ANP, causing a significant decrease in the expressions of TLR4, NF-κB, and cytokine genes in the pancreatic tissue. Conclusions: The expressions of TLR4 and NF-κB were increased in the pancreases of rats with ANP. PDTC not only inhibits NF-κB but also suppresses the expression of TLR4 and downregulates the expression of the related cytokine genes.
참고문헌 (14)
- Algül H, "Acute experimental pancreatitis and NF-kappaB", Rel activation, 2002, pp.2, 503~509
- Liu HS, "Effect of NF-kappaB and p38 MAPK in activated monocytes", macrophages on pro-inflammatory cytokines of rats with acute pancreatitis, 2003, pp.9, 2513~2518
- Gordon S, "Pattern recognition receptors: doubling up for the innate immune response", Cell, 111, pp.927~930 (2002)
- Johnson GB, "Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4", J Immunol, 172, pp.20~24 (2004)
- Huang H, "Activation of nuclear factor-kappaB in acinar cells increases the severity of pancreatitis in mice", Gastroenterology, 144, pp.202~210 (2013)
- Steinle AU, "NF-kappaB", Rel activation in cerulein pancreatitis, 1999, pp.116, 420~430
- Satoh A, "Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis", Gut, 44, pp.253~258 (1999)
- Giakoustidis A, "Dissecting the stress activating signaling pathways in acute pancreatitis", Hepatogastroenterology, 57, pp.653~656 (2010)
- Sah RP, "Pathogenic mechanisms of acute pancreatitis", Curr Opin Gastroenterol, 28, pp.507~515 (2012)
- Virlos I, "Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis", Shock, 20, pp.544~550 (2003)
- Aho HJ, "Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis", Scand J Gastroenterol, 15, pp.411~416 (1980)
- Li Y, "Toll-like receptor 4 detected in exocrine pancreas and the change of expression in cerulein-induced pancreatitis", Pancreas, 30, pp.375~381 (2005)
- Magder S, "Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells", J Vasc Res, 43, pp.447~461 (2006)
- Li L, "TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways", J Cell Sci, 118, pp.555~563 (2005)